Table 1.
Comparison of clinical and pathologic characteristics of breast cancer patients according to the phospho-p90RSK expression
| Low P90RSK | High P90RSK | |||
|---|---|---|---|---|
| Mean age |
|
55.3 (±10.4) |
48.3 (±11.9) |
0.004 |
| Initial tumor size (cm) |
|
5.1 (±2.3) |
5.2 (2.4) |
0.734 |
| cT stage |
cT1-2 |
18 (55%) |
38 (48%) |
0.339 |
| |
cT3-4 |
15 (45%) |
41 (52%) |
|
| cN stage |
cN0-1 |
21 (64%) |
40 (51%) |
0.149 |
| |
cN2-3 |
12 (36%) |
39 (49%) |
|
| pCR |
pCR no |
29 (88%) |
72 (91%) |
0.414 |
| |
pCR yes |
4 (12%) |
7 (9%) |
|
| Estrogen receptor |
ER negative |
18 (55%) |
42 (53%) |
0.530 |
| |
ER positive |
15 (45%) |
37 (47%) |
|
| Progesterone receptor |
PR negative |
10 (67%) |
36 (64%) |
0.560 |
| |
PR positive |
5 (33%) |
20 (36%) |
|
| HER2 overexpression |
HER2 negative |
10 (67%) |
39 (70%) |
0.527 |
| HER2 positive | 5 (33%) | 17 (30%) |